Federica M. Giugliano

Milan, 20122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years.

Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years.

Journal: Breast (Edinburgh, Scotland)

Published: October 17, 2025

Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.

Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.

Journal: The oncologist

Published: June 16, 2025

Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.

Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.

Journal: The oncologist

Published: June 16, 2025

Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies.

Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies.

Journal: Cancer treatment reviews

Published: April 24, 2025

Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology.

Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology.

Journal: Cancer treatment reviews

Published: February 17, 2025

Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort.

Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort.

Journal: ESMO open

Published: July 11, 2024

Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.

Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 03, 2024

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Journal: ESMO open

Published: March 22, 2024

PARP Inhibitors for Breast Cancer Treatment: A Review.

PARP Inhibitors for Breast Cancer Treatment: A Review.

Journal: JAMA oncology

Published: March 21, 2024

Fast Mimicking Diets and Other Innovative Nutritional Interventions to Treat Patients with Breast Cancer.

Fast Mimicking Diets and Other Innovative Nutritional Interventions to Treat Patients with Breast Cancer.

Journal: Cancer treatment and research

Published: January 04, 2024

Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study.

Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 13, 2023

Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer.

Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer.

Journal: Current opinion in oncology

Published: August 25, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026